InvestorsHub Logo
Followers 7
Posts 879
Boards Moderated 0
Alias Born 07/08/2013

Re: None

Tuesday, 12/22/2020 3:00:45 PM

Tuesday, December 22, 2020 3:00:45 PM

Post# of 3712
At he same time as the run up in price there was an article published on TipRanks.com that was bullish. It was at 1:17 pm eastern time today.

The author is Michael Marcus. He sees a price target of 2 or 3 dollars which is a lot higher than 42 cents where it was when he posted his positive statements. He said that the Cannacord analyst also sees real potential for PTN with a price target of $3. That last part is not news as that analyst has been long for years.

I do not see how a fairly unknown person could have an opinion that when stated publicly could have such a dramatic effect on trading.

It could just be a coincidence, but it seems unlikely for such a punctuated change in trading sentiment to occur. Something would have to cause it.

He also talked about the Covid-19 trials starting for one of its clinical trials drugs. That right there might be a big part of the price appreciation, but this last catalyst here is also not breaking news. The Covid-19 trials were announced perhaps months ago.

Perhaps early Covid-19 trial results got leaked, but that is not in the Michael Marcus report.

Whatever the reason, I am glad to see this thing PTN move and show some signs of life. I will hold for at least $2.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTN News